5,6-Dichloropurine-1-(2,3,5-tri-O-acetyl-b-D-ribofuanosyl)-1H-benzimidazole

CAS : 443678-71-5

Ref. 3D-ND16534

Informations sur le produit

• Nom: 5,6-Dichloropurine-1-(2,3,5-tri-O-acetyl-b-D-ribofuanosyl)-1H-benzimidazole
• Synonymes: 5,6-Dichloro-1-(2,3,5-tri-O-acetyl-b-D-ribofuranosyl)-1H-benzimidazole

Description

5,6-Dichloropurine-1-(2,3,5-tri-O-acetyl-b-D-ribofuranosyl)-1H-benzimidazole is an antiviral agent that has shown activity against RNA viruses. It is a modified nucleoside monophosphate that inhibits the synthesis of viral ribonucleic acid (RNA) by binding to the enzyme RNA polymerase. 5,6-Dichloropurine is also a novel anticancer drug with antiangiogenic and antitumor properties. The compound was found to be effective in inhibiting the growth of human cancer cells in vitro. 5,6-Dichloropurine has been shown to inhibit protein synthesis through inhibition of diphosphate activation of ribonucleotide reductase and DNA polymerase. This product is synthesized using high purity and high quality reagents with excellent yield. It can be used as an

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 445.25 g/mol
• Formule: C₁₈H₁₈Cl₂N₂O₇
• Degré de pureté: Min. 95%